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ABSTRACT
In response to stress such as virus infection, cells can stall translation by storing mRNAs away in cellular compartments called
stress granules (SGs). This defense mechanism favors cell survival by limiting the use of energy and nutrients until the stress is
resolved. In some cases it may also block viral propagation as viruses are dependent on the host cell resources to produce viral
proteins. Human norovirus is a member of the Caliciviridae family responsible for gastroenteritis outbreaks worldwide. Previ-
ous studies on caliciviruses have identified mechanisms by which they can usurp the host translational machinery, using the vi-
ral protein genome-linked VPg, or regulate host protein synthesis through the mitogen-activated protein kinase (MAPK) path-
way. Here, we examined the effect of feline calicivirus (FCV) infection on SG accumulation. We show that FCV infection impairs
the assembly of SGs despite an increased phosphorylation of eukaryotic initiation factor eIF2, a hallmark of stress pathway
activation. Furthermore, SGs did not accumulate in FCV-infected cells that were stressed with arsenite or hydrogen peroxide.
FCV infection resulted in the cleavage of the SG-nucleating protein Ras-GTPase activating SH3 domain-binding protein
(G3BP1), which is mediated by the viral 3C-like proteinase NS6Pro. Using mutational analysis, we identified the FCV-induced
cleavage site within G3BP1, which differs from the poliovirus 3C proteinase cleavage site previously identified. Finally, we
showed that NS6Pro-mediated G3BP1 cleavage impairs SG assembly. In contrast, murine norovirus (MNV) infection did not im-
pact arsenite-induced SG assembly or G3BP1 integrity, suggesting that related caliciviruses have distinct effects on the stress
response pathway.
IMPORTANCE
Human noroviruses are a major cause of viral gastroenteritis, and it is important to understand how they interact with the in-
fected host cell. Feline calicivirus (FCV) andmurine norovirus (MNV) are used as models to understand norovirus biology. Re-
cent studies have suggested that the assembly of stress granules is central in orchestrating stress and antiviral responses to re-
strict viral replication. Overall, our study provides the first insight on how caliciviruses impair stress granule assembly by
targeting the nucleating factor G3BP1 via the viral proteinase NS6Pro. This work provides new insights into host-pathogen inter-
actions that regulate stress pathways during FCV infection.
During infection by viruses, the accumulation of RNA replica-tion intermediates or viral proteins imposes major stresses on
the host cell. In response to these stresses, infected cells induce
several defense mechanisms, which include the stress response
pathways and the type I interferon (IFN) pathway. In order to
promote cell survival and limit the use of energy and nutrients,
the stressed host cell induces a global reduction in host protein
synthesis (1). This translational arrest can be triggered by the
phosphorylation of the eukaryotic initiation factor 2 (eIF2)
subunit, which prevents the recycling of the ternary complex
tRNAi
Met-GTP-eIF2 and the delivery of the initiator tRNA to the
ribosome, thereby stalling the initiation of translation (1–4).
While four kinases have been described that can induce eIF2
phosphorylation, protein kinase R (PKR) is specifically activated
by double-stranded RNA (dsRNA) ligands present in the cyto-
plasm of virus-infected cells (1, 2, 5). Consequently, the inhibi-
tion of translation initiation leads to polysome disassembly,
and the mRNAs contained within stalled ribosome complexes
accumulate in cytoplasmic structures called stress granules
(SGs) (4). The resulting inhibition of protein synthesis is prob-
lematic for viruses as they rely on the host cell protein synthesis
machinery for production of their proteins. In turn, many vi-
ruses have evolved strategies to impair these cellular stress re-
sponses by disrupting SG formation during infection or ex-
ploiting SGs for their replication (6–10).
Although the exact composition of SGs remains elusive, their
assembly is driven by aggregation-prone cellular RNA-binding
proteins, such as T cell internal antigen 1 (TIA-1) and Ras-GTPase
activating SH3 domain binding protein 1 (G3BP1), which bind to
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mRNAs, to one another, and subsequently to other cellular pro-
teins, resulting in the formation of SGs (4). Furthermore, recent
proteomic analysis of SG cores revealed that SG assembly is driven
by an intricate network of protein-protein interactions modulated
by ATPases (11). SGs contain mRNAs bound to translation fac-
tors, such as eIF4F and eIF3, and the 40S ribosomal subunit. They
act as dynamic microdomains in which mRNAs are sorted be-
tween decay, storage, and polysome assembly, allowing cells to
rapidly resume translation once stress is alleviated (4, 12, 13).
Given that some viruses trigger the formation of SGs and transla-
tional shutoff through the phosphorylation of eIF2 (14, 15) and
that RIG-I-like receptors and PKR have been shown to localize to
SGs (16–18), it has been proposed that SGs could exert specific
antiviral effects (19).
The Caliciviridae family contains small RNA viruses of both
medical and veterinary importance. Human norovirus (HuNoV)
is a leading cause of acute gastroenteritis worldwide, responsible
for an estimated 18% of cases and 200,000 deaths per annum
(20–23). The genogroup GII genotype 4 (GII.4) strains are re-
sponsible for the majority of outbreaks, including pandemics.
While the symptoms are acute and self-resolving, HuNoV infec-
tion can result in inflammatory bowel disease or neonatal entero-
colitis (24–26) and has been reported to cause persistent infec-
tions in young and elderly populations (27, 28). In animals,
porcine sapovirus and bovine norovirus cause epidemic outbreaks
of gastroenteritis in piglets and calves, respectively (29). Feline
calicivirus (FCV), a member of the Vesivirus genus, causes upper
respiratory tract infections and lethal systemic diseases in cats
(30). Despite recent studies indicating that limited HuNoV repli-
cation can occur in immortalized B cells in the presence of enteric
bacteria, a detailed understanding of human norovirus biology is
limited owing to the lack of robust cell culture systems (31–33).
However, the related caliciviruses murine norovirus (MNV) and
FCV can be propagated in cell culture and remain the most robust
and readily available models to understand the life cycle of calici-
viruses (33, 34).
Members of the Caliciviridae family typically possess genomes
ranging from 7.3 to 8.3 kb in length that have a viral genome-
linked protein (VPg) covalently attached at the 5= end. The VPg
protein interacts with eIFs and acts a proteinaceous cap substitute
(35, 36). While FCV VPg interacts with eIF4E to direct translation,
in MNV it is the VPg interaction with eIF4G that is important for
viral translation (35, 36). In addition, we have recently proposed
that the control of eIF4E activity by the mitogen-activated protein
kinase (MAPK) pathways contributes to calicivirus infection by
regulating the translation of specific host mRNAs implicated in
the antiviral response (37).
Despite these advances in our understanding of how calicivi-
ruses manipulate the host translation machinery, the importance
of stress response pathway activation and SGs in the calicivirus life
cycle has not been addressed. Here, we examined the impact of
FCV infection on SG accumulation. We observed that FCV infec-
tion impaired the assembly of SGs induced in an eIF2-dependent
and -independent manner. We show that this inhibition coincides
with the cleavage of G3BP1 by the FCV protease NS6 at position
405. This study sheds new light on how caliciviruses manipulate
the stress response pathway and possibly the innate antiviral re-
sponses.
MATERIALS AND METHODS
Cells and viruses. Crandell-Rees feline kidney (CRFK) cells (European
Collection of Cell Cultures [ECACC]) were grown in minimum essential
medium (MEM) with Earle’s salts and L-glutamine (Gibco), supple-
mented with 5% fetal bovine serum (FBS), 1% nonessential amino acids,
and 1% (vol/vol) penicillin-streptomycin (5,000 units/ml penicillin G so-
dium and 5,000 /ml streptomycin sulfate in 0.85% saline; Life Technol-
ogies) in a 5% CO2 environment. Feline embryo fibroblast (FEA) cells
(ECACC) were grown in MEM with Earle’s salts and L-glutamine (Gibco),
supplemented with 10% FBS, 1% nonessential amino acids, and 1% (vol/
vol) penicillin-streptomycin (5,000 units/ml penicillin G sodium and
5,000 g/ml streptomycin sulfate in 0.85% saline; Life Technologies) in a
5% CO2 environment. Murine macrophage cells J774.1 (ECACC) were
maintained in Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen)
supplemented with 10% fetal calf serum (FCS; HyClone), 100 U of peni-
cillin/ml, 100 g of streptomycin/ml, 10 mM HEPES, and 2 mM L-glu-
tamine in a 5% CO2 environment. The feline calicivirus (FCV) strain
Urbana and murine norovirus 1 (MNV1) strain CW1 were described
previously (35). Virus titers were estimated by determination of the 50%
tissue culture infectious dose (TCID50) in units per milliliter. For a mul-
tiplicity of infection (MOI) equal to 1, cells were infected with 1 TCID50
unit per cell. Infection of CRFK or FEA cells and of J774 cells was carried
out using multiplicities of infection (MOIs) of 1 and 10, respectively. The
times postinfection refer to the time elapsed following medium replace-
ment after a 1-h inoculation period. HEK293T cells were maintained in
DMEM (Lonza) supplemented with 10% FCS and penicillin-streptomy-
cin (100 U/ml and 100 g/ml; ThermoFisher).
G3BP1 KO engineering. HeLa-R19-G3BP1KO (with knockout [KO]
of G3BP1) cells were generated using the CRISPR/Cas9 system as previ-
ously described (38). Briefly, genomic RNA (gRNA) encoding primer
cassettes to target human G3BP1 (gRNA1, 5=-ACCGTAGTCCCCTG
CTGGTCGGGC-3= and 5=-AACGCCCGACCAGCAGGGGACTAC-3=;
gRNA2, 5=-CCGTATTACACACTGCTGAACCG-3= and 5=-AAACGGTT
CAGCAGTGTGTAATA-3=) were cloned into the SapI restriction sites of
the pCRISPR-hCas9-2xgRNA-Puro plasmid. HeLa-R19 cells were seeded
in six-well clusters (100,000 cells/well) and transfected the next day with
2.5 g of plasmid DNA using FuGENE6 (Promega) according to the
manufacturer’s instructions. The following day, successfully transfected
cells were selected using puromycin, and single-cell clones were generated
using endpoint dilutions. HeLa-R19-G3BP1KO cells were grown in
DMEM (Lonza) supplemented with 10% FCS and penicillin-streptomy-
cin (100 U/ml penicillin G sodium and 100g/ml; ThermoFisher) in a 5%
CO2 environment.
Expression plasmids. Construction of the pCMV-Flag-G3BP1
(where CMV is cytomegalovirus) and pCMV-Flag-G3BP2 plasmids is de-
scribed elsewhere (39). Expression plasmids of mutant Flag-G3BP1 were
developed using site-directed mutagenesis (SDM), and gene integrity was
confirmed by sequence analysis. The pIRES-EGFP-MCS (where IRES is
internal ribosome entry site, EGFP is enhanced green fluorescent protein,
and MCS is multiple cloning site) was constructed by ligating a primer
cassette (5=-GTACAAGCTCGAGATATATGCGGCCGCCTAAT-3= and
5=-CTAGATTAGGCGGCCGCATATATCTCGAGCTT-3=; restriction
sites are underlined) encoding XhoI-NotI restriction sites into the BsrGI-
XbaI restriction sites of pIRES2-EGFP (Clontech). Coding sequences for
FCV-NS6Pro, MNV-NS6Pro, and poliovirus (PV)-3CPro were amplified by
PCR using primers possessing flanking XhoI and NotI restriction sites.
Digested PCR products were ligated into the pIRES-EGFP-MCS plasmid,
and gene integrity was confirmed by sequence analysis.
Overexpression of viral proteinases. HEK293T cells were seeded in
six-well clusters (3.0 105 cells/well) and the next day cotransfected with
a pCMV-Flag-G3BP1 or pCMV-Flag-G3BP2 expression plasmid together
with a pIRES-EGFP expression plasmid (ratio of 1:1; 2.5 g/well) using
FuGENE6 according to the manufacturer’s instructions (Promega). At 16
h posttransfection, cells were collected, washed once with TEN-H buffer
(40 mM Tris-HCl, pH 7.4, 150 mM NaCl, 10 mM EDTA) and lysed in
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TEN-L lysis buffer (40 mM Tris-HCl, pH 7.4, 150 mM NaCl, 10 mM
EDTA, 1% NP-40, Complete Mini protease inhibitor cocktail [Roche]).
Lysates were incubated for 15 min on ice, and cell debris was cleared using
centrifugation (15 min at 15,000  g). Protein concentration was deter-
mined using a bicinchoninic acid (BCA) assay (Pierce), and proteins were
subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE).
Induction of SGs. To induce SG formation, cells were treated with 0.5
mM sodium arsenite (Sigma) for 30 min (CRFK and HeLa cells) or 45 min
(J774 cells) or 50M for 1h (HeLa cells) or with 1 mM hydrogen peroxide
(Sigma) for 1 h.
Preparation and analysis of whole-cell extracts. Cells were washed
twice with cold phosphate-buffered saline (PBS) and then scraped into
lysis buffer (50 mM HEPES, pH 7.4, 150 mM NaCl, 2 mM EDTA, 2 mM
Na3VO4, 25 mM disodium -glycerophosphate, Complete Mini protease
inhibitor cocktail [1 tablet per 50 ml of buffer; Roche], 0.5% NP-40). Cell
lysates were incubated on ice for 5 min before centrifugation at 14,000
g for 5 min at 4°C in a microcentrifuge (Mikro 22R; Hettich Zentrifugen).
For immunoblotting analysis during infection, standard protocols were
used to separate cell lysates by SDS-PAGE, using 5 to 20g of extracts, and
proteins were transferred to polyvinylidene difluoride membranes. These
were probed with the primary antibodies G3BP1 (611126; BD Biosci-
ences,), G3BP2 (A302-040A; Bethyl), MNV1 NS7 (40), FCV NS6/7 (35),
poly(A)-binding protein (PAPB) (sc-28834; Santa Cruz), 4E-BP1 Ser65
(9451; Cell Signaling), 4E-BP1 Thr37/46 (9459; Cell Signaling,), 4E-BP1
(9452; Cell Signaling,), glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (AM4300; Ambion), eIF2 (9722; Cell Signaling), and eIF2
Ser52 (44-728G; Invitrogen), followed by incubation with the appropriate
peroxidase-labeled secondary antibody (Dako) and chemiluminescence
development using SuperSignal West Pico chemiluminescence substrate
(Pierce). The signals were detected on radiographic film (Fuji; New Eng-
land BioLabs). For immunoblotting analysis during overexpression ex-
periments, membranes were successively incubated for 1 h with the pri-
mary antibody G3BP1, G3BP2, Flag-M2 (F3165; Sigma-Aldrich), EGFP
(OSE00003G; Invitrogen), or tubulin (T6074; Sigma-Aldrich) and then
for 30 min with goat anti-mouse labeled with IRDye 680 (Li-Cor) or goat
anti-rabbit labeled with IRDye 800 (Li-Cor). The signals were detected by
scanning the membranes using an Odyssey Imager (Li-Cor).
Immunofluorescencemicroscopy. J774 cells grown on poly-L-lysine-
treated coverslips were infected with MNV1 at an MOI of 10 and fixed for
15 min with 4% paraformaldehyde in PBS at the time points indicated on
the figures. For arsenite stress, cells were treated with 0.5 mM sodium
arsenite for 45 min before fixation and immunostaining. Cells were then
permeabilized for 5 min with PBS– 0.2% Triton X-100, and unspecific
antigens were blocked for 1 h using 2% normal goat serum (S2007; Sigma)
in PBS– 0.1% Tween 20 (PBST). Cells were then incubated for 1 h with
primary antibodies in PBST at a dilutions 1:2,000 (anti-NS3 MNV; non-
commercial rabbit polyclonal) and 1:500 (anti-G3BP1, mouse monoclo-
nal [611126; BD Biosciences]). After extensive washes with PBST, species-
matched Alexa Fluor-conjugated secondary antibodies (A-11037 and
A-11029; ThermoFisher Scientific) were added at a dilution of 1:500 in
PBST for one additional hour. Coverslips were extensively washed and
mounted on slides with Mowiol supplemented with 4=,6=-diamidino-2-
phenylindole (DAPI) and 1,4-diazabicyclo[2.2.2]octane (DABCO). Con-
focal micrographs were acquired on a Leica TCS SP5 confocal micro-
scope fitted with a 63 (1.3 numerical aperture [NA]) oil immersion
objective using 488-nm and 594-nm laser excitation lines under se-
quential channel scanning to prevent fluorophore bleed-through arti-
facts due to spectral overlap.
CRFK cells grown on coverslips were infected with FCV Urbana at an
MOI of 1 and fixed for 1 h with 4% paraformaldehyde in PBS at the time
points indicated on the figures. Cells were then permeabilized for 5 min
with PBS– 0.1% Triton X-100, and unspecific antigens were blocked for 30
min using 1% bovine serum albumin (BSA) in PBS (PBS-BSA). Cells were
then incubated for 1 h with primary antibodies in PBS-BSA at dilutions of
1:150 (anti-eIF4G, rabbit polyclonal [sc-11373; Santa-Cruz]), 1:400 (anti-
G3BP1, mouse monoclonal [611126; BD biosciences]), 1:600 (anti-
NS6/7, rabbit polyclonal [35]), and 1:10,000 (anti-VP1, mouse polyclonal
[35]). After extensive washes with PBS, species-matched Alexa Fluor-con-
jugated secondary antibodies (A-21424 and A-11034; ThermoFisher Sci-
entific) were added at a dilution of 1:400 in PBS-BSA for one additional
hour. Coverslips were extensively washed and then incubated in To-Pro-3
(T3605; ThermoFisher Scientific) for 10 min before being mounted on
slides with Vectashield (H1000; Vector Laboratories). Confocal micro-
graphs were acquired on a Zeiss LSM510 VIS Meta confocal microscope
fitted with a 40 (1.3 NA) oil immersion objective using 488-nm, 594-
nm, and 633-nm laser excitation lines under sequential channel scanning
to prevent fluorophore bleed-through artifacts due to spectral overlap.
HeLa-R19-G3BP1KO cells were grown on coverslips in 24-well clusters
and the next day cotransfected with a pCMV-Flag-G3BP1 or pCMV-Flag-
G3BP1-E405A expression plasmid together with a pIRES-EGFP or pIRES-
EGFP-FCV-NS6 expression plasmid (ratio of 4:1; 0.5 g/well) using Fu-
GENE6 according to the manufacturer’s instructions (Promega). The
following day, cells were treated with 50 M arsenite for 1 h and fixed for
30 min with 4% paraformaldehyde in PBS. Cells were then permeabilized
for 5 min with PBS– 0.2% Triton X-100, and unspecific antigens were
blocked for 1 h using 2% BSA in PBS (PBS-BSA). Cells were then incu-
bated for 1 h with primary antibodies in PBS-BSA at dilutions of 1:500
(anti-eIF3, goat polyclonal [sc-16377; Santa-Cruz]) and 1:1,000 (anti-
G3BP1, mouse monoclonal [611126; BD Biosciences]). After extensive
washes with PBS, species-matched Alexa Fluor-conjugated secondary an-
tibodies (A-11058 and A-31571; ThermoFisher Scientific) were added at a
dilution of 1:100 with DAPI (1g/ml) in PBS-BSA for 30 min. Coverslips
were extensively washed and mounted on glass slides in FluorSafe (Calbi-
ochem). Cells were examined by confocal microscopy (Leica SPE-II).
For the quantification of SGs, a minimum of 500 cells for three inde-
pendent replicates were analyzed. Cells were considered SG positive if two
or more SG marker foci were present in the cytoplasm. Statistical analyses
were then performed using GraphPad software. All error bars represent
standard deviations calculated from a minimum of three independent
biological replicates. Analysis of variance (ANOVA) was applied to the
data sets to calculate P values.
RESULTS
eIF2 is phosphorylated in FCV-infected cells. Rapidly after in-
fection, the accumulation of viral products, such as RNA replica-
tion intermediates or viral proteins, acts as the trigger for the cel-
lular stress response pathways (1, 2). The recognition of viral RNA
by PKR promotes the phosphorylation of the translation factor
eIF2 and elicits potent innate immune responses (3). To exam-
ine the effect of FCV infection on the host cell, we monitored the
levels of phosphorylated eIF2. To this end, the lysates from
mock- and FCV-infected CRFK cells, at 2 or 6 h postinfection
(hpi), were fractionated by SDS-PAGE and analyzed by immuno-
blotting. As shown on Fig. 1, the levels of total eIF2 were not
affected during infection. However, FCV infection resulted in
eIF2 phosphorylation at 2 and 6 hpi, a similar response to that
seen following sodium arsenite treatment, a potent inducer of
eIF2 phosphorylation via the kinase HRI (41).
FCV infection does not cause accumulation of SGs. eIF2
phosphorylation prevents the recycling of the ternary complex
tRNAi
Met-GTP-eIF2 and the delivery of the initiator tRNA to the
ribosome, thereby stalling the initiation of translation and result-
ing in a shutdown of protein synthesis. Following this transla-
tional arrest, mRNAs contained within stalled ribosome com-
plexes accumulate in cytoplasmic structures called SGs (4).
Therefore, we investigated whether FCV infection also resulted in
the formation of SGs. CRFK cells were infected for 8 h and then
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stained with antisera specific for NS6/7, a viral protein, and
G3BP1, a marker of SGs, at various times postinfection. Cells were
then examined by immunofluorescence microscopy to determine
whether FCV-infected cells contained SGs. We observed that, de-
spite eIF2 phosphorylation, FCV infection failed to trigger SG
accumulation throughout the replication cycle (Fig. 2A). The
quantification of the number of cells displaying G3BP1 foci did
not increase significantly during infection (Fig. 2C). To confirm
these results, we also examined the accumulation of another SG
marker, eIF4G, during FCV infection. Again, FCV infection did
not result in an increase of eIF4G cytoplasmic foci (Fig. 2B and C).
To investigate whether CRFK cells are able to form SGs upon
stress pathway activation, CRFK cells were treated for 30 min with
0.5 mM arsenite. This treatment resulted in the relocalization of
FCV -    +    -    +
GAPDH
NS6/7
2 hpi 6 hpi
p-eIF2α
(S52)
eIF2α
SA -   + 
mock
FIG 1 eIF2 phosphorylation during FCV infection. CRFK cells were mock
infected or infected with FCV Urbana at an MOI of 1 for 2 or 6 h as indicated.
As a control, CRFK cells were treated with 0.5 mM sodium arsenite (SA;) for
30 min or mock treated (). Following treatments, cell extracts were prepared
and analyzed by SDS-PAGE and immunoblotting using the antibodies indi-
cated on the left side of the panel. p-eIF2, phospho-eIF2.
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FIG 2 SG accumulation during FCV infection. (A) CRFK cells were mock infected or infected with FCV Urbana at an MOI of 1. Infected cells, with () or
without () sodium arsenite (SA) treatment, were fixed at the times indicated postinfection and stained with either mouse monoclonal antibodies specific for
G3BP1 and rabbit polyclonal antiserum specific for FCV NS6/7 (A) or mouse polyclonal antibodies specific for VP1 and rabbit polyclonal antiserum specific for
eIF4G (B). This was followed by staining with Alexa Fluor 488-conjugated donkey anti-rabbit IgG and Alexa Fluor 555-conjugated donkey anti-mouse IgG
secondary antibodies. Nuclei were stained with To-Pro-3. Stained cells were examined by fluorescence microscopy, and representative images are shown. (C) The
percentage of cells containing SGs out of the total number of cells was calculated, and the means of and standard deviations of three experimental replicates are
shown. Results were analyzed by one-way ANOVA with Bonferroni corrections: ***, P	 0.001 (GraphPad Prism, version 6).
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G3BP1 and eIF4G to discrete cytoplasmic foci (Fig. 2A and B).
Thus, these data suggest that FCV infection does not induce the
accumulation of SGs, despite the induction of eIF2 phosphory-
lation.
FCV infection blocks the formation of SGs in response to
arsenite treatment. The absence of SGs in FCV-infected CRFK
cells, despite eIF2 phosphorylation, suggested that FCV infec-
tion could impair the assembly of SGs, potentially disconnecting
the cellular signals that mediate the accumulation of SGs. To ex-
amine whether FCV infection could block SG formation in re-
sponse to exogenous stress triggers, we monitored arsenite-in-
duced SG formation in mock- and FCV-infected cells. CRFK cells
were mock or FCV infected for 6 h, treated with arsenite for 30
min, and then fixed and stained for immunofluorescence micros-
copy. In mock-infected cells, arsenite-induced SGs were detected
in 90% of cells (Fig. 3A and B). In contrast, no significant induc-
tion of SG assembly could be detected in FCV-infected cells (Fig.
3A and B). To determine whether this absence of SGs was due to
viral replication, the experiment was repeated with UV-inacti-
vated virus, which is replication incompetent (Fig. 3C). FCV in-
activation restored the ability of infected cells to assemble SGs in
response to arsenite treatment to levels similar to those in mock-
infected cells (Fig. 3A and B). Thus, FCV replication impairs the
formation of SGs in response to stress pathway activation.
FCV infection impairs the assembly of hydrogen peroxide-
induced SGs. The absence of SGs in FCV-infected CRFK cells
following arsenite stress, despite the occurrence of eIF2 phos-
phorylation, suggested that FCV infection impairs SG formation.
Next, we tested whether FCV infection would also interfere with
the accumulation of SGs mediated by eIF2-independent trans-
lational stalling. Previous studies have suggested that hydrogen
peroxide stress results in 4EBP1 dephosphorylation, leading to
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was calculated, and the means and standard deviations of three experimental replicates are shown. Results were analyzed by one-way ANOVA with Bonferroni
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eIF4E sequestration. This, in turn, induces the disassembly of the
eIF4F complex, translational stalling, and SG accumulation (42).
First, to confirm that hydrogen peroxide induced translation in-
hibition in our experimental system, CRFK cells were treated with
hydrogen peroxide, and 4EBP1 phosphorylation was assessed by
immunoblotting using antibodies specific for phosphorylated
4EBP1. Hydrogen peroxide treatment resulted in dephosphoryla-
tion of 4EBP1 at T36/47 and S65 (Fig. 4A). Given that S65 is one of
the two main phosphorylation sites (along with T70) that controls
the ability of 4EBP1 to sequester eIF4E, while the phosphorylation
at T36/47 is not directly linked to eIF4E binding (43), we con-
cluded that hydrogen peroxide stress of CRFK cells induces trans-
lational impairment, as expected. Next, mock- or FCV-infected
CRFK cells were exposed at 6 hpi to hydrogen peroxide, and the
accumulation of SGs was evaluated by immunofluorescence mi-
croscopy using G3BP1 as an SG marker. While 87.7% of mock-
infected cells assembled SGs in response to hydrogen peroxide,
FCV-infected cells were unable to assemble SGs (Fig. 4B and C).
Together, these data suggest that FCV infection impairs the as-
sembly of SGs that are triggered via eIF2-dependent and inde-
pendent pathways.
FCV infection results in the cleavage of the SG-nucleating
protein G3BP1. The absence of SGs following translational arrest
mediated by both eIF2-dependent and -independent pathways
suggested that FCV infection might impair the ability of cells to
assemble SGs. Previous studies have demonstrated that SG inhi-
bition could be driven by the sequestration of SG-nucleating pro-
teins or the cleavage of the SG-nucleating component G3BP1 (8).
For example, G3BP1 cleavage is mediated by the proteinase 3CPro
of poliovirus (PV), a virus that belongs to the Picornaviridae fam-
ily (44). Caliciviruses share a similar genome organization with
picornaviruses and express a proteinase related to the 3CPro,
namely, 3C-like protease (3CLPro) or NS6Pro (45). In addition to
cleaving viral proteins, NS6Pro can target cellular proteins such as
PABP to regulate translation during infection (46). Therefore, we
investigated whether FCV infection could result in G3BP1 cleav-
age, explaining the absence of SG accumulation upon arsenite or
hydrogen peroxide treatment. Lysates from mock- and FCV-in-
fected CRFK cells were fractionated by SDS-PAGE and analyzed
by immunoblotting. As shown in Fig. 5, FCV infection resulted in
the degradation of PABP from 4 hpi while levels of GAPDH re-
mained constant (Fig. 5A). In addition, from 4 hpi onwards, a
smaller cleavage product from G3BP1 could be detected. At 6 hpi,
most of the full-length G3BP1 was cleaved into the short form
(Fig. 5A). We also analyzed the impact of FCV infection on
G3BP2, a G3BP1 homolog protein recruited to SGs (47). Our
results suggest that G3BP2 is also impacted by FCV infection (Fig.
5A) although this is only evident at 6 hpi. To confirm these results,
we infected FEA cells with FCV. Similarly to the results observed
with CRFK cells, infection of FEA cells with FCV resulted in the
cleavage of G3BP1 into a shorter form (Fig. 5B). Of note, we could
not detect the presence of G3BP2 in FEA cells (data not shown).
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The FCV, but not MNV, NS6Pro cleaves G3BP1 and G3BP2.
To further establish whether the FCV NS6Pro is directly responsi-
ble for the cleavage of G3BP1 observed, we expressed the FCV
NS6Pro and PV 3CPro as EGFP fusion proteins in HEK293T cells.
While the expression of EGFP alone had no impact on G3BP1, the
expression of the EGFP-PV 3CPro resulted in the cleavage of en-
dogenous G3BP1 (Fig. 6A). The expression of EGFP-FCV NS6Pro
also resulted in the cleavage of G3BP1; however, the cleavage
product detected differed from the one generated by EGFP-PV
3CPro and more closely resembled the products observed in virus-
infected cells (Fig. 6A). We also analyzed the impact of viral pro-
teases on G3BP2, a G3BP1 homolog protein recruited to SGs (47).
While EGFP-PV 3CPro had no impact on G3BP2 integrity, G3BP2
cleavage was detected in cells expressing EGFP-FCV NS6Pro. To
confirm these findings, we analyzed the impact of EGFP-PV 3CPro
and EGFP-FCV NS6Pro on overexpressed Flag-G3BP1 and Flag-
G3BP2 in HEK293T cells. Again, we observed that both EGFP-PV
3CPro and EGFP-FCV NS6Pro were able to cleave the Flag-G3BP1
fusion protein and that the cleavage products were of different
sizes (Fig. 6B). Moreover, Flag-G3BP2 was efficiently cleaved by
EGFP-FCV NS6Pro while EGFP-PV 3CPro expression resulted in
only weak cleavage at several distinct sites (Fig. 6B). These results
suggest that the impairment of SG assembly during FCV infection
may be due to the NS6Pro-mediated cleavage of both G3BP1 and
G3BP2. Next, we analyzed whether the expression of NS6Pro from
a related calicivirus would also impact G3BP1 and G3BP2 integ-
rity. However, the expression of EGFP-MNV NS6Pro did not result
in cleavage of G3BP1 or G3BP2 (Fig. 6A and B). This suggests that
this new pattern of G3BP1 and G3BP2 cleavages is restricted to
FCV infection rather than being conserved in caliciviruses.
FCVNS6Pro cleaves G3BP1 at position E405. Our results sug-
gest that FCV NS6Pro cleaves G3BP1 at a position that differs from
the previously identified PV 3CPro cleavage at Q325 (Fig. 6C). To
confirm this, we overexpressed wild-type (wt) or Flag-G3BP1 with
the Q325A substitution and analyzed the impact on EGFP-FCV
NS6Pro cleavage efficacy. As previously shown, the Q325A substi-
tution inhibited the cleavage mediated by EGFP-PV 3CPro (7);
however, this did not prevent cleavage mediated by EGFP-FCV
NS6Pro (Fig. 6D), confirming that FCV NS6Pro and PV 3CPro
cleave G3BP1 at distinct positions. Previous studies have shown
that FCV NS6Pro could induce proteolysis at the following P1-P1=
junctions: E/A, D/A, Q/A, E/V, E/R, E/L, E/G, and E/H (48). To
further determine the cleavage site, we replaced all Q and E resi-
dues with A residues in the G3BP1 C-terminal region, yielding a
cleavage product of around 8 to 12 kDa (Fig. 6C). The impact of
these substitutions was then evaluated by monitoring wild-type or
mutant Flag-G3BP1 integrity during the coexpression with EGFP-
FCV NS6Pro. While the E355A, Q361A, E368, E389A, and Q392A
substitutions did not prevent G3BP1 cleavage, the E405A substi-
tution rendered Flag-G3BP1 resistant to EGFP-FCV NS6Pro cleav-
age (Fig. 6D). These results suggest that FCV NS6Pro mediates the
cleavage of G3BP1 at E405/V406.
FCVNS6Pro-mediatedG3BP1 cleavage impairs SG assembly.
To confirm that G3BP1 cleavage at E405 by FCV NS6Pro would
indeed impair SG formation, we analyzed the impact of the E405A
mutation on FCV NS6Pro-mediated inhibition of SG formation.
First, we confirmed that both Flag-G3BP1 wt and E405A localize
to SGs in HeLa-R19-G3BP1KO cells generated by the CRISPR/
Cas9 system (Fig. 7A and B). Coexpression of Flag-G3BP1 wt or
Flag-G3BP1 E405A, together with an EGFP control, in the pres-
ence of sodium arsenite resulted in the accumulation of both Flag-
G3BP1 wt and Flag-G3BP1 E405A in cytoplasmic foci that are also
positive for eIF3. The colocalization of the tagged G3BP1 with
eIF3 strongly suggests that the recombinant Flag-G3BP1 proteins
accumulate in SGs and that the E405A mutation does not affect SG
formation (Fig. 7A). As expected, the coexpression of Flag-G3BP1
wt with EGFP-FCV NS6Pro in the presence of sodium arsenite re-
sulted in diffused cytoplasmic localization of Flag-G3BP1 wt, reflect-
ing an impaired ability to assemble SGs when G3BP1 is cleaved by
FCV NS6Pro. In stark contrast, the coexpression of Flag-G3BP1
E405A with EGFP-FCV NS6Pro in the presence of sodium arsenite
restored the ability of cells to assemble SGs, as noted by the accumu-
lation of G3BP1 foci (Fig. 7A). Thus, G3BP1 cleavage at E405 by the
FCV NS6Pro is sufficient to impair SGs accumulation.
MNV infection does not impair SG assembly following a
stress trigger. In the absence of G3BP1 cleavage by MNV NS6Pro
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(Fig. 6A), we hypothesized that MNV-infected cells would be able
to assemble SGs in response to arsenite treatment. To test this,
murine J774 cells were infected with MNV for 8 or 16 h, followed
by immunoblotting analysis. At both 8 and 16 hpi, no G3BP1
cleavage product could be detected (Fig. 8A). Furthermore, MNV
infection of J774 cells resulted in eIF2 phosphorylation, which
increased during the late stages of the viral life cycle, i.e., at 8 to 16
hpi (Fig. 8A). The formation of SGs at 8 and 16 hpi was then
analyzed by immunofluorescence microscopy using G3BP1 as an
SG marker and NS3 as a marker for viral protein accumulation.
J774 cells can assemble SGs in response to sodium arsenite treat-
ment, as evidenced by the accumulation of G3BP1 foci (Fig. 8B).
In contrast with FCV infection, MNV infection resulted in the
assembly of SGs (Fig. 8B). Interestingly, some of these G3BP1 foci
seem to colocalize with NS3. Given that MNV NS3 accumulates in
replication complexes during infection, further studies will aim at
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dissecting a putative interaction between SGs and replication
complexes (49). Importantly, MNV infection did not impair the
accumulation of SGs in MNV-infected cells stimulated with so-
dium arsenite at either 8 or 16 hpi. Therefore, unlike FCV, MNV
infection does not impair the ability of cells to form SGs, at least in
the culture system examined here, and we propose that this is due
to the absence of G3BP1 cleavage.
DISCUSSION
Viral infections cause major stress for the infected host cell that in
many cases can culminate in translational arrest. The stress-in-
duced translational repression is a consequence of reduced trans-
lation initiation that can result from impairing the assembly
of the eIF4F complexes or preventing the recycling of the
tRNAi
Met-GTP-eIF2 ternary complex through eIF2 phosphoryla-
tion (1). This inhibition of translation leads to polysome disas-
sembly and the formation of SGs through the binding of RNA-
binding proteins to nontranslating mRNAs. Translational arrest is
problematic for all viruses as they depend on the host cell protein
synthesis machinery for the production of viral proteins. There-
fore, many viruses antagonize the stress response pathway and SG
formation during infection. The mechanism by which this antag-
onism occurs varies depending on the viruses and the host cells;
several patterns of SG accumulation have been described, includ-
ing complete inhibition of SGs, stable formation of SGs, and os-
cillation of SGs (8, 9, 50). In some cases viral gene products can act
as antagonists by targeting the virus-activated eIF2 kinases PKR
and PKR-like endoplasmic reticulum kinase (PERK) or even by
directly modulating the phosphorylation of eIF2 (16, 50–54). In
this study, we show that although FCV infection results in the
phosphorylation of eIF2, reflecting the activation of stress path-
ways, SGs do not accumulate in FCV-infected cells (Fig. 1 and 2).
We further demonstrate that FCV infection impairs SG assembly
in response to translational arrest driven by eIF2 phosphoryla-
tion and also by eIF4F complex disruption (Fig. 3 and 4). This
suggests that FCV does not target the stress response signaling
pathway but only the downstream formation of SGs.
Several RNA viruses have been shown to express viral effectors
that can actively disrupt the accumulation of SGs through seques-
tration or cleavage of SG components (8, 9). The nonstructural
proteins of several alphaviruses redirect SG-nucleating protein
into viral replication complexes to disrupt SG accumulation, such
as FGDF motifs within Semliki Forest virus (SFV) nsP3, which
binds G3BP1 (55–58). The infections of several picornaviruses
such as poliovirus, coxsackievirus B3, enterovirus 71, and en-
cephalomyocarditis virus result in the transient formation of SGs
(44, 59, 60). Following their early assembly, viral proteinases can
disperse SGs by cleaving the SG-nucleating protein G3BP1 (44,
59–61). The calicivirus NS6Pro proteins cysteine proteinases that
adopt chymotrypsin-like folds similar to those of 3C proteinases
from picornaviruses (62, 63). We therefore hypothesized that
FCV infection may result in G3BP1 cleavage. Indeed, the analysis
of FCV-infected cells, in two cell lines supporting FCV infection,
revealed that G3BP1 undergoes cleavage from 4 hpi (Fig. 5).
To directly show that the FCV NS6Pro is responsible for G3BP1
cleavage, we overexpressed FCV NS6Pro and analyzed the impact
on G3BP1 integrity (Fig. 6). Our results demonstrate that FCV
NS6Pro cleaves G3BP1, while NS6Pro from another calicivirus,
MNV, does not and that the G3BP1 cleavage product differs from
the one generated by the PV 3CPro. While the PV 3CPro cleaves
between residues Q325/G326, our mutational analysis identified
the FCV NS6Pro cleavage site at E405/V406. By overexpressing the
wild-type or noncleavable G3BP1, together with FCV NS6Pro, and
by challenging cells with sodium arsenite, we demonstrated that
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preventing NS6Pro-mediated G3BP1 cleavage rescues the forma-
tion of SGs (Fig. 7). Therefore, this confirms that the cleavage of
G3BP1 during FCV infection may act as a major contributor to the
inhibition of SG assembly. G3BP1 contains several functional do-
mains, such as an N-terminal NTF2-like domain, central PXXP
motifs, and two C-terminal RNA binding domains, with an RRM
motif followed by an RGG motif. While PV 3CPro cleaves off both
RNA binding domains, a property conserved in other enterovi-
ruses, FCV NS6Pro cleaves G3BP1 between the RRM and the RGG
motifs, targeting only the C-terminal domain. Thus, the modular
scaffold of RNA-binding elements within G3BP1 can be differen-
tially targeted by viral proteinase to cleave G3BP1.
To explain the absence of SG inhibition following MNV infec-
tion and G3BP1 cleavage by MNV NS6Pro, we compared the se-
quences of the human, feline, and murine G3BP1 proteins (Fig.
6C). The FCV NS6Pro cleavage site is conserved between human
and cat, which could explain the impairment of SG assembly dur-
ing FCV infection. However, murine G3BP1 has at position 405 an
alanine instead of the aspartate found in feline and human G3BP1
proteins. The previous determination of the MNV NS6Pro struc-
ture in complex with a substrate sequence revealed that three
amino acids, H157, T134, and Y143, make extensive contacts with
the side chain carbonyl of a glutamate residue at the cleavage site.
Therefore, the presence of an alanine in the murine G3BP1 could
explain the lack of cleavage by the MNV NS6Pro during infection
and, consequently, the ability of MNV-infected cells to assemble
SGs in response to arsenite treatment, at least in J774 cells (Fig. 8).
However, this does not explain why MNV NS6Pro is unable to
cleave G3BP1 when it is expressed in human cells (Fig. 6A). We
could speculate that differences in amino acids surrounding the
NS6Pro catalytic triad between MNV and FCV could potentially
impact the substrate recognition. The recognition of G3BP1 by
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NS6Pro from different caliciviruses will be the subject of further
structural investigation studies beyond the scope of this study.
G3BP2 is a G3BP1 homolog with a similar domain organization
(64). Like G3BP1, G3BP2 is important for SG formation and is
sequestered by chikungunya virus nsP3 to disassemble SGs late in
infection (39, 47, 65). Recently, it was shown that G3BP2 is not
cleaved by PV 3CPro, questioning the importance of G3BP2 in SG
assembly (66). Our study shows that G3BP2 can also be cleaved by
FCV NS6Pro, suggesting that both G3BP homologs are targeted by
FCV NS6Pro (Fig. 6). This observation correlates with the fact that
the G3BP1 cleavage site is conserved in human and feline G3BP2
(G3BP1, 402FRGE/VRLN409; G3BP2, 396FRGE/VRLN403). How-
ever, overexpression of noncleaved G3BP1 is sufficient to restore
SG formation under conditions where G3BP2 is cleaved. There-
fore, further work will be necessary to dissect the contribution of
G3BP2 cleavage to the inhibition of SGs.
Increasing evidence has suggested a functional link between
the induction of SGs by viruses and the initiation of innate
antiviral responses (8, 19, 67). The observations that there is a
correlation between SG formation and IFN production and a
reverse correlation between SG formation and viral propaga-
tion and that pattern recognition receptors are localized in
virus-induced SGs together with viral non-self RNAs together
strongly suggest that SGs have an antiviral role and possibly
function as a platform to initiate innate antiviral responses
(16–18, 59, 67–69). Overall, virus-induced SGs might play dual
roles: (i) suppressing viral replication through an inhibition of
viral protein synthesis, and (ii) serving as a platform to facili-
tate IFN production. Our observation that FCV inhibits SG
assembly and that NS6Pro cleaves G3BP1 may reflect one of the
many strategies that caliciviruses have evolved to control the
host antiviral response.
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